/ Unknown statusPhase 1/2IIT A Clinical Study of the Safety and Efficacy of Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops Treatment for Dry Eye Diseases Post Refractive Surgery and Associated With Blepharospasm
The purpose of this study is to evaluate the preliminary safety and effectiveness of Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops in the treatment of dry eye diseases post refractive surgery and associated with blepharospasm
100 Clinical Results associated with Hangzhou Protobiology Technology Co., Ltd.
0 Patents (Medical) associated with Hangzhou Protobiology Technology Co., Ltd.
100 Deals associated with Hangzhou Protobiology Technology Co., Ltd.
100 Translational Medicine associated with Hangzhou Protobiology Technology Co., Ltd.